1498 related articles for article (PubMed ID: 18715157)
21. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients.
Masjedi MR; Tabarsi P; Baghaei P; Jalali S; Farnia P; Chitsaz E; Amiri M; Mansouri D; Velayati AA
Int J Infect Dis; 2010 May; 14(5):e399-402. PubMed ID: 19818664
[TBL] [Abstract][Full Text] [Related]
22. Drug susceptibility patterns of Mycobacterium tuberculosis and clinical outcomes of drug-resistant tuberculosis at Srinagarind Hospital, a tertiary care center in northeastern Thailand.
Reechaipichitkul W; Tubtim S; Chaimanee P
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1154-62. PubMed ID: 22299441
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Rosales S; Pineda-García L; Andino N; Almendarez N; Membreño H; Hoffner SE
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1542-9. PubMed ID: 19919774
[TBL] [Abstract][Full Text] [Related]
24. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
[TBL] [Abstract][Full Text] [Related]
25. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
26. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226
[TBL] [Abstract][Full Text] [Related]
27. [Frequency of MDR-TB/XDR-TB strains isolated from chronic pulmonary tuberculosis patients in Japan].
Kazumi Y; Itagaki N; Ohmori M; Wada M; Hoshino H; Mitarai S; Sugawara I; Ishikawa N; Mori T
Kekkaku; 2007 Dec; 82(12):891-6. PubMed ID: 18188977
[TBL] [Abstract][Full Text] [Related]
28. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
[TBL] [Abstract][Full Text] [Related]
29. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
Fattorini L; Migliori GB; Cassone A
Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
[TBL] [Abstract][Full Text] [Related]
30. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
Mendoza MT; Gonzaga AJ; Roa C; Velmonte MA; Jorge M; Montoya JC; Tan Torres T; Ong M; Barez MY; Ang CF
Int J Tuberc Lung Dis; 1997 Feb; 1(1):59-63. PubMed ID: 9441060
[TBL] [Abstract][Full Text] [Related]
31. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
32. Drug-resistant tuberculosis in Taipei, 1996-1999.
Wang PD; Lin RS
Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
Jones KD; Hesketh T; Yudkin J
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
[TBL] [Abstract][Full Text] [Related]
34. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
[TBL] [Abstract][Full Text] [Related]
35. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
[TBL] [Abstract][Full Text] [Related]
36. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
38. Extensively drug-resistant tuberculosis: epidemiology and management challenges.
Dheda K; Warren RM; Zumla A; Grobusch MP
Infect Dis Clin North Am; 2010 Sep; 24(3):705-25. PubMed ID: 20674800
[TBL] [Abstract][Full Text] [Related]
39. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
Koenig R
Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
[No Abstract] [Full Text] [Related]
40. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
